Rectal Cancer
Low Grade Adenocarcinoma of Rectum
Female, 45 years
Patient Internal ID: 1523433869
ICD-10 code
C20 Malignant Neoplasm of Rectum
Diagnosis (Incl. Metastases/Stage) and Year
July 2021
Low Grade Adenocarcinoma of Rectum ypT2N0cM0, KRAS G12 mutation. Disease progression in November of 2022, Metastasis in Right Lung, mass on the Right Pelvic wall. Disease progression in February of 2024, 3 Metastases in the Brain.
Previous Treatment
Chemotherapy (FOLFOX), Surgery, Chemotherapy (FLOX), Target Therapy (Nivolumab).
Prognosis and Survival Expectation
The prognosis remains poor for Advanced Rectal Cancer, with a median survival of ~28 months from diagnosis.
Treatment Provided
Autologous DCV (4 doses) and CIK (4 doses) over a period of 4 months.
Patient Survival/Condition and Year
Date of Review: 10/02/2024
The patient has survived for 32 months since the diagnosis and 15 months since disease progression. The latest CT scan has shown further disease progression in the Brain. The patient will receive SBRT, therefore no conclusions can be made so far.
